This inventor holds 3 USPTO granted patents. Top assignee: Wesley-Jessen Corporation. Active years: 1997-1999.
Location History:
- Drogheda, IE (1997)
- Collon, IE (1998 - 1999)
Company Filing History:
Years Active: 1997-1999
Title: John T Mulvihill: Innovating UV-absorbing Benzotriazoles for Ocular Devices
Introduction:
John T Mulvihill is an exceptional inventor and researcher hailing from Collon, Ireland. With a passion for chemistry and materials science, Mulvihill has made significant contributions to the field of polymers and ocular devices. Currently associated with the esteemed Wesley Jessen Company, Mulvihill's expertise lies in the development of UV-absorbing benzotriazoles that are utilized in the production of ultraviolet absorbing polymers.
Latest Patents:
One of Mulvihill's recent patent applications involves the creation of UV-absorbing benzotriazoles with a styrene group. These reactive monomers possess a unique chemical formula (I), where R1 can be a halogen or a C1-C6 straight or branched chain alkoxy group. The compound's structure enables the production of ultraviolet absorbing polymers, particularly those used in ocular devices like contact and intraocular lenses.
Ocular Device Comprising UV-Absorbing Benzotriazoles:
Another noteworthy patent application by Mulvihill pertains to ocular devices incorporating UV-absorbing benzotriazoles with styrene. Here, he uses a reactive monomer with the chemical formula (I), where R1 represents a halogen or a C1-C6 straight or branched chain alkoxy group, and R2 varies between --(CH2)3O--, --(CH2)2O--, --CH(CH3)CH2O--, --CH2CH(CH3)O--, --(CH2)3OCH2--, --(CH2)2OCH2--, --CH(CH3)CH2OCH2--, or --CH2CH(CH3)OCH2--. This innovation enhances the ability of ocular devices to shield the eyes from potentially harmful ultraviolet radiation.
Career Highlights:
Mulvihill's career has been marked by his exceptional contributions to the field of polymers, particularly in relation to ocular devices. His work at Wesley Jessen Company has been pivotal in advancing the development and optimization of ultraviolet absorbing polymers for ocular applications.
Collaborations:
Within Wesley Jessen Company, Mulvihill collaborates closely with his coworker, Theresa A Collins. Through their combined efforts, they strive to push the boundaries of polymer science and ocular device design, constantly seeking innovative solutions to protect and enhance people's eye health.
Conclusion:
John T Mulvihill's impressive portfolio of patents and innovations underscores his dedication to advancing ocular device technology. His pioneering work in the synthesis of UV-absorbing benzotriazoles with a styrene group has paved the way for improved ultraviolet protection in lenses and other ocular applications. Mulvihill's collaborations and involvement with Wesley Jessen Company make him an invaluable asset to the field of polymers and ocular device development.